One in two postmenopausal women and one in five older men are at risk for an osteoporosis-related fracture. And a new study finds a majority of medications prescribed for the disorder are both ...

Current therapies for osteoporosis have greatly altered the natural history of the disease. Their efficacy is limited, however, by adverse effects, long-term safety concerns, and poor compliance.

Q : I was diagnosed with osteoporosis four years ago. I started taking Actonel. I recently read that Actonel and similar drugs are suspected of increasing the risk of fractures in the femur. What&#… ...

Drugs called bisphosphonates are the most common treatment for osteoporosis. Some other drugs may be tried if these are ineffective. ... Is Hormone Therapy for Menopause Safe? Updated on May 7, 2024.

Although antiresorptive drugs are widely used to treat postmenopausal osteoporosis, they are unable to stimulate bone formation. The use of anabolic agents has, therefore, been proposed as an ...

Q: I read your article on osteoporosis ("Saving Your Bones: Hard Choices," Sept. 15) with great interest. My older sister and I both have osteoporosis, and I've been reluctant to go on ...

Osteoporosis drug denosumab has been found safe for postmenopausal women in a long-term trial. Tuesday, Jun 24, 2025. New Delhi o C. Subscribe. Sign in. My Account. Subscribe.

"Osteoporosis is a chronic condition and therefore requires long-term treatment, so it's really important to know what happens in the long run when you treat it," said the director of the Fosamax ...

"Osteoporosis is a chronic condition and therefore requires long-term treatment, so it's really important to know what happens in the long run when you treat it," said the director of the Fosamax ...

The new study, the longest clinical trial ever conducted in osteoporosis, found that Fosamax enabled postmenopausal women to maintain or increase their bone density through 10 years of treatment, with ...